Use of an alkylating agent from the symm. triazine group on malignant tumors of the ovaries
Kotova, D.G.; Zel'dovich, D.R.; Maliugina, L.L.
Voprosy Onkologii 21(3): 100-101
1975
ISSN/ISBN: 0507-3758 PMID: 124108 Document Number: 93180
Document emailed within 1 workday
Related Documents
Cristalli, B. 1991: Malignant tumors of the ovaries Soins. Gynecologie Obstetrique Puericulture Pediatrie 126: 15-18Riazantsev, E.L.; Gorbunova, E.A.; Egorova, A.F.; Barykina, V.V. 1987: Advisability of relaparotomy after non-radical surgery for malignant tumors of the uterus and ovaries Voprosy Onkologii 33(11): 92
Kotova, D.G.; Lipova, V.A. 1979: Antitumor action of preparation No. 31 in malignant tumors of the ovaries (a clinical cytological study) Voprosy Onkologii 25(3): 24-27
Syrovatko, F.A.; Nesterova, A.A. 1970: Quick diagnosis of malignant tumors of the ovaries using the radioindication method with radioactive phosphorus (P32) Akusherstvo i Ginekologiia 46(3): 11-14
Pankov, A.K.; Smiller, R.R.; Il'inskaia, E.G.; Shurygina, E.A. 1973: Functional state of the adrenal cortex in malignant tumors of the ovaries during thio-TEPA treatment Voprosy Onkologii 19(4): 31-35
Schröder, W.; Bau, O. 1990: Rare malignant tumors of the ovaries in adolescents--clinical aspects in deciding therapeutic aggressiveness Zentralblatt für Gynakologie 112(10): 633-640
Zhou, W.C.; Xin, Z.M.; Zhang, X.P.; Shen, J.; Qiu, Q.P. 1996: Synthesis and antiprotozoal activities of some new triazine derivatives including a new antitrypanosomal agent: SIPI-1029 Yao Xue Xue Bao 31(11): 823-830
Zarivchatskiĭ, M.F.; Sokolov, I.S.; Lunegov, A.I.; Iagovkin, V.F. 1981: Gelvisol as a symptomatic agent for treating generalized forms of malignant tumors Voprosy Onkologii 27(3): 53-57
Miller, J.L.; Hulbert, P.B. 1976: Hycanthone: an alkylating agent [proceeding Journal of Pharmacy and Pharmacology 28 Suppl: 18p
Tura, S.; Mazza, P.; Gherlinzoni, F.; Zinzani, P.L.; Poletti, G.; Visani, G.; Lemoli, R.M.; Bandini, G.; Cavo, M.; Galieni, P. 1988: Phase Ii study with a new alkylating agent (PTT-119) in lymphoid malignancies Haematologica 73(6): 503-508
Iamshchikov, N.V. 1981: Ultrastructural analysis of reactive changes in the myocardium upon embryo exposure to an alkylating agent Arkhiv Anatomii Gistologii i Embriologii 80(3): 64-68
Ecknauer, R. 1976: Morphology and enzyme aktivity in rat small intestinal epithelium 6 and 12 hrs. after an alkylating agent (cyclophosphamide) Acta Hepato-Gastroenterologica 23(5): 365-371
Gardella, S.; Cervantes, F.; Bladé, J.; Brugués, R.; Rozman, C. 1982: Acute myeloproliferative syndrome after alkylating agent treatment in a case of multiple myeloma Medicina Clinica 79(4): 185-188
Russo, J.E.; Hilton, J.; Colvin, O.M. 1989: The role of aldehyde dehydrogenase isozymes in cellular resistance to the alkylating agent cyclophosphamide Progress in Clinical and Biological Research 290: 65-79
Dobrosława, S.-S.śn.; Wacław, S. 2012: Fertility sparing surgical treatment of malignant ovarian tumors in the reproductive age group of women Ginekologia Polska 83(1): 27-32
Rob, L.; Svoboda, B.; Robová, H.; Stankusová, H.; Cwiertka, K.; Neumannová, R.; Petera, J.; Koliba, P.; Kudela, M. 2004: Guideline for gynecological malignant tumors--primary complex therapy in operable stages of malignant tumors of uterus cervix Ceska Gynekologie 69(5): 376-383
Durando, C. 1984: Current possibilities of the timely diagnosis, preoperative staging and prevention of malignant tumors of the ovary. A) Diagnostic problem of malignant ovarian tumors Minerva Ginecologica 36(4): 143-144
Lemoli, R.M.; Visani, G.; Tosi, P.; Mazza, P.; Motta, M.R.; Rizzi, S.; Zinzani, P.L.; Poluzzi, C.; Gherlinzoni, F.; Tura, S. 1988: Effects of a new bifunctional alkylating agent (PTT-119) on in vitro growth of human cell lines and normal myeloid progenitors (CFU-GM) Haematologica 73(3): 195-200
Lisker, S.A. 1970: Chemotherapy for malignant disease: the alkylating agents Delaware Medical Journal 42(5): 127-130
Tobey, R.A.; Tesmer, J.G. 1985: Differential response of cultured human normal and tumor cells to trace element-induced resistance to the alkylating agent melphalan Cancer Research 45(6): 2567-2571